Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review
The DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We conducted a systematic review of studies evaluating the cost-effectiveness (CE) of interventions to prevent type 2 diabetes (T2D) among high-risk individuals and whole populations. RESEARCH DESIGN AND METHODS: Interventions targeting high-risk individuals are those that identify people at high risk of developing T2D and then treat them with either lifestyle or metformin interventions. Population-based prevention strategies are those that focus on the whole population regardless of the level of risk, creating public health impact through policy implementation, campaigns, and other environmental strategies. We systematically searched seven electronic databases for studies published in English between 2008 and 2017. We grouped lifestyle interventions targeting high-risk individuals by delivery method and personnel type. We used the median incremental cost-effectiveness ratio (ICER), measured in cost per quality-adjusted life year (QALY) or cost saved to measure the CE of interventions. We used the $50,000/QALY threshold to determine whether an intervention was cost-effective or not. ICERs are reported in 2017 U.S. dollars. RESULTS: Our review included 39 studies: 28 on interventions targeting high-risk individuals and 11 targeting whole populations. Both lifestyle and metformin interventions in high-risk individuals were cost-effective from a health care system or a societal perspective, with median ICERs of $12,510/QALY and $17,089/QALY, respectively, compared with no intervention. Among lifestyle interventions, those that followed a Diabetes Prevention Program (DPP) curriculum had a median ICER of $6,212/QALY, while those that did not follow a DPP curriculum had a median ICER of $13,228/QALY. Compared with lifestyle interventions delivered one-on-one or by a health professional, those offered in a group setting or provided by a combination of health professionals and lay health workers had lower ICERs. Among population-based interventions, taxing sugar-sweetened beverages was cost-saving from both the health care system and governmental perspectives. Evaluations of other population-based interventions—including fruit and vegetable subsidies, community-based education programs, and modifications to the built environment—showed inconsistent results. CONCLUSIONS: Most of the T2D prevention interventions included in our review were found to be either cost-effective or cost-saving. Our findings may help decision makers set priorities and allocate resources for T2D prevention in real-world settings.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
Guidelines for authors and peer reviewers of economic submissions to the BMJ
Drummond, M. F., & Jefferson, T. O. (1996) · BMJ · doi:10.1136/bmj.313.7052.275 · Cited by 1,827
The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study
Bommer, C., Heesemann, E., Sagalova, V., Manne-Goehler, J., Atun, R., Bärnighausen, T., & Vollmer, S. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30097-9 · Cited by 816
Ali, M. K., Echouffo-Tcheugui, J. B., & Williamson, D. F. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.1009 · Cited by 594
Braithwaite, R. S., Meltzer, D. O., King, J. T., Leslie, D., & Roberts, M. S. (2008) · Medical Care · doi:10.1097/mlr.0b013e31815c31a7 · Cited by 579
Dunkley, A. J., Bodicoat, D. H., Greaves, C. J., Russell, C., Yates, T., Davies, M. J., & Khunti, K. (2014) · Diabetes Care · doi:10.2337/dc13-2195 · Cited by 542
Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review
Li, R., Zhang, P., Barker, L. E., Chowdhury, F. M., & Zhang, X. (2010) · Diabetes Care · doi:10.2337/dc10-0843 · Cited by 491
Self-citationImpact of the Berkeley Excise Tax on Sugar-Sweetened Beverage Consumption
Falbe, J., Thompson, H. R., Becker, C. M., Rojas, N., McCulloch, C. E., & Madsen, K. A. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303362 · Cited by 464
The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention
The Diabetes Prevention Program Research Group (2012) · Diabetes Care · doi:10.2337/dc11-1468 · Cited by 436
Ely, E. K., Gruss, S. M., Luman, E. T., Gregg, E. W., Ali, M. K., Nhim, K., Rolka, D. B., & Albright, A. L. (2017) · Diabetes Care · doi:10.2337/dc16-2099 · Cited by 386 · cited 1×
“translational program providing a framework and infrastructure for targeting high-risk individuals, and this program is covered by several commercial and public insurers (65).”
BackgroundSelf-citationHaw, J. S., Galaviz, K. I., Straus, A. N., Kowalski, A. J., Magee, M. J., Weber, M. B., Wei, J., Narayan, K. M. V., & Ali, M. K. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.6040 · Cited by 354
Cost Effectiveness of Community-Based Physical Activity Interventions
Roux, L., Pratt, M., Tengs, T. O., Yore, M. M., Yanagawa, T. L., Van Den Bos, J., Rutt, C., Brownson, R. C., Powell, K. E., Heath, G., et al. (2008) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.06.040 · Cited by 325
Cost-Effectiveness of Interventions to Promote Physical Activity: A Modelling Study
Cobiac, L. J., Vos, T., & Barendregt, J. J. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000110 · Cited by 310
A systematic review of real-world diabetes prevention programs: learnings from the last 15 years
Aziz, Z., Absetz, P., Oldroyd, J., Pronk, N. P., & Oldenburg, B. (2015) · Implementation Science · doi:10.1186/s13012-015-0354-6 · Cited by 305
Preventing Type 2 Diabetes in Communities Across the U.S.
Albright, A. L., & Gregg, E. W. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.009 · Cited by 297
Self-citationGillies, C. L., Lambert, P. C., Abrams, K. R., Sutton, A. J., Cooper, N. J., Hsu, R. T., Davies, M. J., & Khunti, K. (2008) · BMJ · doi:10.1136/bmj.39545.585289.25 · Cited by 290
A Penny-Per-Ounce Tax On Sugar-Sweetened Beverages Would Cut Health And Cost Burdens Of Diabetes
Wang, Y. C., Coxson, P., Shen, Y.-M., Goldman, L., & Bibbins-Domingo, K. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.0410 · Cited by 221
Sánchez-Romero, L. M., Penko, J., Coxson, P. G., Fernández, A., Mason, A., Moran, A. E., Ávila-Burgos, L., Odden, M., Barquera, S., & Bibbins-Domingo, K. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002158 · Cited by 201
Sun, Y., You, W., Almeida, F., Estabrooks, P., & Davy, B. (2017) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2016.11.016 · Cited by 186
Fiscal policy to improve diets and prevent noncommunicable diseases: from recommendations to action
Thow, A. M., Downs, S. M., Mayes, C., Trevena, H., Waqanivalu, T., & Cawley, J. (2018) · Bulletin of the World Health Organization · doi:10.2471/blt.17.195982 · Cited by 177
Beverages Sales in Mexico before and after Implementation of a Sugar Sweetened Beverage Tax
Colchero, M. A., Guerrero-López, C. M., Molina, M., & Rivera, J. A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0163463 · Cited by 174
The Impact of a Tax on Sugar-Sweetened Beverages on Health and Health Care Costs: A Modelling Study
Veerman, J. L., Sacks, G., Antonopoulos, N., & Martin, J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151460 · Cited by 168
3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s003 · Cited by 162
Cobiac, L. J., Tam, K., Veerman, L., & Blakely, T. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002232 · Cited by 152
Li, R., Qu, S., Zhang, P., Chattopadhyay, S., Gregg, E. W., Albright, A., Hopkins, D., & Pronk, N. P. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0469 · Cited by 152
Self-citationRoberts, S., Barry, E., Craig, D., Airoldi, M., Bevan, G., & Greenhalgh, T. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017184 · Cited by 122
Tate, D. F., Lyons, E. J., & Valle, C. G. (2015) · Diabetes Spectrum · doi:10.2337/diaspect.28.1.45 · Cited by 117
Screening Adults for Pre-Diabetes and Diabetes May Be Cost-Saving
Chatterjee, R., Narayan, K. M. V., Lipscomb, J., & Phillips, L. S. (2010) · Diabetes Care · doi:10.2337/dc10-0054 · Cited by 111
Choi, S. E., Seligman, H., & Basu, S. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.12.013 · Cited by 94
Effectiveness and cost-effectiveness of diabetes prevention among adherent participants.
Herman, W. H., Edelstein, S. L., Ratner, R. E., Montez, M. G., Ackermann, R. T., Orchard, T. J., Foulkes, M. A., Zhang, P., Saudek, C. D., & Brown, M. B. (2013) · PubMed · Cited by 91
Self-citationMekonnen, T. A., Odden, M. C., Coxson, P. G., Guzman, D., Lightwood, J. M., Wang, Y. C., & Bibbins-Domingo, K. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081723 · Cited by 90
Zhuo, X., Zhang, P., Gregg, E. W., Barker, L., Hoerger, T. J., Pearson-Clarke, T., & Albright, A. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.1115 · Cited by 82
Self-citationBasu, S., Seligman, H. K., & Bhattacharya, J. (2013) · Medical Decision Making · doi:10.1177/0272989x13493971 · Cited by 80
Manyema, M., Veerman, J. L., Chola, L., Tugendhaft, A., Labadarios, D., & Hofman, K. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143050 · Cited by 73
Using An Economic Model Of Diabetes To Evaluate Prevention And Care Strategies In Australia
Colagiuri, S., & Walker, A. E. (2008) · Health Affairs · doi:10.1377/hlthaff.27.1.256 · Cited by 61
Prevalence of Major Behavioral Risk Factors for Type 2 Diabetes
Siegel, K. R., Bullard, K. M., Imperatore, G., Ali, M. K., Albright, A., Mercado, C. I., Li, R., & Gregg, E. W. (2018) · Diabetes Care · doi:10.2337/dc17-1775 · Cited by 58
Self-citationMoin, T., Ertl, K., Schneider, J., Vasti, E., Makki, F., Richardson, C., Havens, K., & Damschroder, L. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4332 · Cited by 53
Palmer, A. J., & Tucker, D. M. D. (2012) · Primary Care Diabetes · doi:10.1016/j.pcd.2011.10.006 · Cited by 53
Saha, S., Carlsson, K. S., Gerdtham, U., Eriksson, M. K., Hagberg, L., Eliasson, M., & Johansson, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080672 · Cited by 51
Breeze, P. R., Thomas, C., Squires, H., Brennan, A., Greaves, C., Diggle, P. J., Brunner, E., Tabak, A., Preston, L., & Chilcott, J. (2017) · Diabetic Medicine · doi:10.1111/dme.13314 · Cited by 50
Breeze, P. R., Thomas, C., Squires, H., Brennan, A., Greaves, C. J., Diggle, P. J., Brunner, E. J., Tabák, Á. G., Preston, L., & Chilcott, J. B. (2017) · Diabetic Medicine · doi:10.1111/dme.13349 · Cited by 48
Cost Effectiveness of Preventive Screening Programmes for Type 2 Diabetes Mellitus in Germany
Schaufler, T., & Wolff, M. (2010) · Applied Health Economics and Health Policy · doi:10.2165/11532880-000000000-00000 · Cited by 46
Kolu, P., Raitanen, J. A., Puhkala, J., Tuominen, P. P. A., Husu, P., & Luoto, R. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167759 · Cited by 43
Peels, D. A., Hoogenveen, R. R., Feenstra, T. L., Golsteijn, R. H., Bolman, C., Mudde, A. N., Wendel-Vos, G. C., de Vries, H., & Lechner, L. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-1099 · Cited by 42
Liu, X., Li, C., Gong, H., Cui, Z., Fan, L., Yu, W., Zhang, C., & Ma, J. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-729 · Cited by 42
Neumann, A., Lindholm, L., Norberg, M., Schoffer, O., Klug, S. J., & Norström, F. (2017) · The European Journal of Health Economics · doi:10.1007/s10198-016-0851-9 · Cited by 42
Potential Policy Approaches to Address Diet-Related Diseases
Jacobson, M. F., Krieger, J. W., & Brownell, K. D. (2018) · JAMA · doi:10.1001/jama.2018.7434 · Cited by 39
Wong, C. K. H., Jiao, F.-F., Siu, S.-C., Fung, C. S. C., Fong, D. Y. T., Wong, K.-W., Yu, E. Y. T., Lo, Y. Y. C., & Lam, C. L. K. (2016) · Journal of Diabetes Research · doi:10.1155/2016/1219581 · Cited by 39
Oostdam, N., Bosmans, J., Wouters, M. G., Eekhoff, E. M., van Mechelen, W., & van Poppel, M. N. (2012) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-12-64 · Cited by 38
Neamah, H. H., Kuhlmann, A. S., & Tabak, R. G. (2016) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721716630386 · Cited by 38
Leal, J., Ahrabian, D., Davies, M. J., Gray, L. J., Khunti, K., Yates, T. E., & Gray, A. M. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013592 · Cited by 38
Smith, K. J., Hsu, H., Roberts, M. S., Kramer, M. K., Orchard, T. J., Piatt, G., Seidel, M. C., Zgibor, J. C., & Bryce, C. L. (2010) · PubMed · doi:10.13016/3sh9-kyx5 · Cited by 37
Png, M. E., & Yoong, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107225 · Cited by 37
Pomeranz, J. L., Zellers, L., Bare, M. G., & Pertschuk, M. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.07.027 · Cited by 37
Neumann, A., Schwarz, P., & Lindholm, L. (2011) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-9-17 · Cited by 36
Alternative HbA1c Cutoffs to Identify High-Risk Adults for Diabetes Prevention
Zhuo, X., Zhang, P., Selvin, E., Hoerger, T. J., Ackermann, R. T., Li, R., Bullard, K. M., & Gregg, E. W. (2012) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.01.003 · Cited by 35
Self-citationZhuo, X., Zhang, P., Kahn, H. S., & Gregg, E. W. (2013) · Diabetes Care · doi:10.2337/dc13-0497 · Cited by 31
Self-citationvan Wier, M. F., Lakerveld, J., Bot, S. D. M., Chinapaw, M. J. M., Nijpels, G., & van Tulder, M. W. (2013) · BMC Family Practice · doi:10.1186/1471-2296-14-45 · Cited by 26
Wilson, K. J., Brown, H. S., & Bastida, E. (2014) · Health Promotion Practice · doi:10.1177/1524839914537274 · Cited by 24
Lin, J., Zhuo, X., Bardenheier, B. H., Rolka, D. B., Gregg, E. W., Hong, Y., Wang, G., Albright, A. L., & Zhang, P. (2017) · Diabetes Care · doi:10.2337/dc16-1186 · Cited by 23
Self-citationFeldman, I., Hellström, L., & Johansson, P. (2013) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-11-19 · Cited by 20
Hagenaars, L. L., Jeurissen, P., & Klazinga, N. (2018) · Public Health Nutrition · doi:10.1017/s1368980018002008 · Cited by 19
Medicare’s Intensive Behavioral Therapy for Obesity
Hoerger, T. J., Crouse, W. L., Zhuo, X., Gregg, E. W., Albright, A. L., & Zhang, P. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.11.008 · Cited by 17
Self-citationCost-effectiveness of SHINE: A Telephone Translation of the Diabetes Prevention Program
Hollenbeak, C. S., Weinstock, R. S., Cibula, D. A., Delahanty, L. M., & Trief, P. M. (2016) · Health Services Insights · doi:10.4137/hsi.s39084 · Cited by 12
Sugar-sweetened beverage taxation in the USA, state preemption of local efforts
Pomeranz, J. L., & Pertschuk, M. (2018) · Public Health Nutrition · doi:10.1017/s136898001800304x · Cited by 6
Research works printed but not linked: 3
- International Diabetes Federation, 2019, IDF Diabetes Atlas
- Centers for Disease Control Prevention, 2020, National Diabetes Statistic Report, 2020
- International Diabetes Federation, 2016, Cost-Effective Solutions for the Prevention of Type 2 Diabetes
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
Obesity Management in Adults: A Review
Elmaleh-Sachs, A., Schwartz, J. L., Bramante, C. T., Nicklas, J. M., Gudzune, K. A., & Jay, M. (2023) · JAMA · doi:10.1001/jama.2023.19897 · Cited by 813
Introduction: Standards of Medical Care in Diabetes—2022
American Diabetes Association (2022) · Diabetes Care · doi:10.2337/dc22-sint · Cited by 807
Metadata
- Authors
- Zhou, X., Siegel, K. R., Ng, B. P., Jawanda, S., Proia, K. K., Zhang, X., Albright, A. L., & Zhang, P.
- Affiliations
- Centers for Disease Control and Prevention (US)
- University of Central Florida (US)
- Oak Ridge Institute for Science and Education (US)
- Corresponding author
- Zhang, Ping
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-06-11
- Volume
- 43
- Issue
- 7
- Pages
- 1593-1616
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W3035894501
- Semantic Scholar
- d3d0aa492aa63ebbd3b3bb0388faca0d497a3190
- Cited by
- 173
- References
- 67
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 43 · 2023: 33 · 2022: 24 · 2021: 20 · 2020: 6
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes prevention, cost-effectiveness, high-risk individuals, population-based prevention, lifestyle intervention, metformin, Diabetes Prevention Program, sugar-sweetened beverage tax, fruit and vegetable subsidies, community-based education, lay health workers, incremental cost-effectiveness ratio
- MeSH terms
- Adult, Aged, Cost-Benefit Analysis, Diabetes Mellitus, Type 2, Endocrinology, Health Expenditures, Health Promotion, Humans, Life Style, Metformin, Middle Aged, Patient Education as Topic, Population Surveillance, Prediabetic State, Preventive Medicine, Risk Factors, Health Care Costs, Quality-Adjusted Life Years, Community Networks, Risk Reduction Behavior, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.